Daxor
5 hedge funds and large institutions have $595K invested in Daxor in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.04% less ownership
Funds ownership: 1.38% → 1.34% (-0.04%)
5% less capital invested
Capital invested by funds: $628K → $595K (-$32.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$4.85K |
| 2 |
JP Morgan Chase
New York
|
+$19 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$22.5K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$960 |
DXR Hedge Fund Activity: Q3 2023 in Review
5 of the 6,312 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q3 2023, worth a combined $595K — down 5.2% from $628K a quarter earlier.
Fund positioning in DXR was balanced in Q3 2023: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $4.85K. The largest seller was UBS Group, cutting an estimated $22.5K.
- 5 institutional investors held Daxor (DXR) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $595K of Daxor stock for Q3 2023, down 5.2% quarter-over-quarter.
- 1 fund opened new Daxor positions in Q3 2023 and 1 closed out, a net change of 0 holders.
- The largest Daxor buyer in Q3 2023 was Renaissance Technologies, an estimated $4.85K added.
- The largest Daxor seller in Q3 2023 was UBS Group, an estimated $22.5K sold.
Based on aggregated 13F filings for Q3 2023.